Alpha 2.0
Login Register
» Articles » PMID: 26060333

High-Throughput Screening for Biomarker Discovery

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2015 Jun 11
PMID 26060333
Citations 7
Authors
Tavan Janvilisri
Haruo Suzuki
Joy Scaria
Jenn-Wei Chen
Varodom Charoensawan
Affiliations
Soon will be listed here.
Citing Articles

Decoding the Immune Response and Its Biomarker B2M for High Altitude Pulmonary Edema in Rat: Implications for Diagnosis and Prognosis.

Yuan M, Wan W, Xing W, Pu C, Wu X, Liao Z J Inflamm Res. 2024; 17:7195-7217.

PMID: 39411751 PMC: 11476754. DOI: 10.2147/JIR.S477633.

B2M is a Biomarker Associated With Immune Infiltration In High Altitude Pulmonary Edema.

Yuan M, Hu X, Xing W, Wu X, Pu C, Guo W Comb Chem High Throughput Screen. 2023; 27(1):168-185.

PMID: 37165489 PMC: 10804239. DOI: 10.2174/1386207326666230510095840.

Targeting metabolism: A potential strategy for hematological cancer therapy.

Tang X, Chen F, Xie L, Liu S, Mai H World J Clin Cases. 2022; 10(10):2990-3004.

PMID: 35647127 PMC: 9082716. DOI: 10.12998/wjcc.v10.i10.2990.

CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells.

Shen L, Li C, Chen F, Shen L, Li Z, Li N Cell Death Discov. 2021; 7(1):392.

PMID: 34907164 PMC: 8671510. DOI: 10.1038/s41420-021-00783-8.

WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma.

Ngernsombat C, Prattapong P, Larbcharoensub N, Khotthong K, Janvilisri T Curr Oncol. 2021; 28(4):2529-2539.

PMID: 34287269 PMC: 8293245. DOI: 10.3390/curroncol28040230.